Generex Biotech (GNBT) Files $150M Mixed Shelf
Generex Biotechnology Corp. (NASDAQ GNBT) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $150 million of Common Stock, Preferred Stock, Warrants, Units, or any combination thereof.
Create E-mail AlertRelated Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
